• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在南部非洲进行的一项艾滋病预防试验中,子宫帽和润滑剂凝胶的用户体验及可接受性特征。

User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.

作者信息

Sahin-Hodoglugil Nuriye Nalan, Montgomery Elizabeth, Kacanek Deborah, Morar Neetha, Mtetwa Sibongile, Nkala Busisiwe, Philip Jessica, Ramjee Gita, Cheng Helen, van der Straten Ariane

机构信息

School of Public Health, University of California, Berkeley, USA.

出版信息

AIDS Care. 2011 Aug;23(8):1026-34. doi: 10.1080/09540121.2010.543879.

DOI:10.1080/09540121.2010.543879
PMID:21480005
Abstract

Methods for Improving Reproductive Health in Africa (MIRA), a phase III HIV prevention trial, was conducted among 5039 Zimbabwean and South African women to test the Ortho All-Flex diaphragm and Replens(®) lubricant gel. Among the 2418 intervention group participants, 105 women who had completed the trial and 41 male partners participated in focus group discussions and in-depth interviews about the acceptability of the diaphragm and gel and their experiences using the study products. Women who participated in the qualitative study had exited the trial in the prior nine months, were HIV negative, and used the diaphragm and gel for 12-24 months. The comprehensive and flexible conceptual framework was applied to investigate the salient attributes for acceptability of the products as potential HIV prevention methods, and emerging themes for acceptability were framed within three categories of attributes (product, relationship, and sexual intercourse attributes). Both diaphragm and gel were found to be highly acceptable in the study group, and the gel was popular due to its effect of enhancing sexual pleasure. Some of the important product attributes influencing acceptability as reported by users were convenience, ease of use, dual use potential for contraception and disease prevention, and being female-initiated. It was also noted that some elements (such as sexual pleasure, couple communication, and the necessity of diaphragm negotiation) could be more important than others in terms of influencing product acceptability and use. Acceptability attributes reflective of the broader contextual environment (beliefs generated in the trial community suggesting preventive efficacy - preventive method optimism - and gendered norms favoring male superiority in sexual decision making) also emerged as important themes. The high level of acceptability of the diaphragm and gel among MIRA trial participants and their male partners is an indicator of the continued need for an effective female-initiated product.

摘要

“非洲改善生殖健康方法”(MIRA)是一项三期HIV预防试验,在5039名津巴布韦和南非女性中开展,以测试奥豪全柔型子宫帽和Replens®润滑凝胶。在2418名干预组参与者中,105名完成试验的女性和41名男性伴侣参与了焦点小组讨论和深入访谈,内容涉及子宫帽和凝胶的可接受性以及他们使用研究产品的体验。参与定性研究的女性在之前九个月退出了试验,HIV检测呈阴性,且使用子宫帽和凝胶12至24个月。采用全面且灵活的概念框架来调查产品作为潜在HIV预防方法的可接受性的显著属性,可接受性的新出现主题被归入三类属性(产品、关系和性交属性)。研究组发现子宫帽和凝胶都具有很高的可接受性,凝胶因能增强性快感而受到欢迎。用户报告的一些影响可接受性的重要产品属性包括便利性、易用性、避孕和疾病预防的双重用途潜力以及由女性主动使用。还指出,在影响产品可接受性和使用方面,一些因素(如性快感、伴侣沟通以及协商使用子宫帽的必要性)可能比其他因素更重要。反映更广泛背景环境的可接受性属性(试验社区中产生的表明预防效果的信念——预防方法乐观主义——以及在性决策中有利于男性主导地位的性别规范)也成为重要主题。MIRA试验参与者及其男性伴侣对子宫帽和凝胶的高度可接受性表明,仍然需要一种有效的由女性主动使用的产品。

相似文献

1
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.在南部非洲进行的一项艾滋病预防试验中,子宫帽和润滑剂凝胶的用户体验及可接受性特征。
AIDS Care. 2011 Aug;23(8):1026-34. doi: 10.1080/09540121.2010.543879.
2
Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa.在南部非洲进行的一项有效性试验中,女性对隔膜和润滑剂凝胶的接受程度、使用技巧及使用模式。
Eur J Contracept Reprod Health Care. 2009 Dec;14(6):410-9. doi: 10.3109/13625180903215430.
3
The use of the diaphragm instead of condoms in a phase III diaphragm trial.在一项三期子宫帽试验中使用子宫帽而非避孕套。
AIDS Behav. 2009 Jun;13(3):564-72. doi: 10.1007/s10461-008-9504-z. Epub 2008 Dec 16.
4
A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa.在撒哈拉以南非洲地区开展的一项艾滋病预防试验中,关于使用隔膜和避孕套的障碍的定性研究。
AIDS Educ Prev. 2012 Feb;24(1):54-67. doi: 10.1521/aeap.2012.24.1.54.
5
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.在南非,接受度和使用情况 (包括) 避孕膜和 Replens 润滑剂凝胶用于 HIV 预防。
AIDS Behav. 2010 Jun;14(3):629-38. doi: 10.1007/s10461-009-9609-z. Epub 2009 Sep 10.
6
The importance of discreet use of the diaphragm to Zimbabwean women and their partners.谨慎使用子宫托对津巴布韦女性及其伴侣的重要性。
AIDS Behav. 2007 May;11(3):443-51. doi: 10.1007/s10461-006-9190-7. Epub 2006 Dec 8.
7
Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis.一种杀微生物剂/子宫托组合产品安全性和可行性试验期间性行为的变化:一项定性与定量综合分析
AIDS Educ Prev. 2007 Aug;19(4):310-20. doi: 10.1521/aeap.2007.19.4.310.
8
Barrier method preferences and perceptions among Zimbabwean women and their partners.津巴布韦女性及其伴侣对屏障避孕法的偏好与认知
AIDS Behav. 2005 Dec;9(4):415-22. doi: 10.1007/s10461-005-9013-2.
9
Establishing a continuum of care between HIV prevention trials and public healthcare systems: the MIRA Standard of Care program.建立艾滋病毒预防试验与公共医疗保健系统之间的连续护理:MIRA 标准护理计划。
Clin Trials. 2010 Jun;7(3):256-64. doi: 10.1177/1740774510368299. Epub 2010 Apr 26.
10
Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in south-western Uganda.乌干达西南部女性对避孕套及女性主导的预防艾滋病毒和性传播感染保护措施的态度。
AIDS Care. 1999 Dec;11(6):687-98. doi: 10.1080/09540129947596.

引用本文的文献

1
Barriers and Enablers Influencing Women's Adoption and Continuation of Vaginally Inserted Contraceptive Methods: A Literature Review.影响女性采用和继续使用阴道置入式避孕方法的障碍和促进因素:文献综述。
Stud Fam Plann. 2022 Sep;53(3):455-490. doi: 10.1111/sifp.12209. Epub 2022 Aug 3.
2
Lubricants for the promotion of sexual health and well-being: a systematic review.促进性健康和幸福的润滑剂:系统评价。
Sex Reprod Health Matters. 2021;29(3):2044198. doi: 10.1080/26410397.2022.2044198.
3
Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
了解在干预措施扩大背景下,用户对口腔 PrEP 用于 HIV 预防的看法和偏好:来自撒哈拉以南非洲的综合证据。
J Int AIDS Soc. 2019 Jul;22 Suppl 4(Suppl Suppl 4):e25306. doi: 10.1002/jia2.25306.
4
Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography.撒哈拉以南非洲地区女性主导的生物医学HIV预防产品的采用与使用的动机及障碍:一项适应性元民族志研究
BMC Public Health. 2017 Dec 19;17(1):968. doi: 10.1186/s12889-017-4959-3.
5
The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept.避孕措施的性可接受性:文献综述与新概念构建
J Sex Res. 2016 May-Jun;53(4-5):417-56. doi: 10.1080/00224499.2015.1134425. Epub 2016 Mar 8.
6
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.优化针对女性的艾滋病预防措施:杀微生物剂研究证据综述及引入对性别敏感的杀微生物剂的考量
J Int AIDS Soc. 2015 Dec 21;18(1):20536. doi: 10.7448/IAS.18.1.20536. eCollection 2015.
7
Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省夫妻间关于杀微生物剂使用的交流
AIDS Behav. 2015 May;19(5):832-46. doi: 10.1007/s10461-014-0965-y.
8
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.CAPRISA 004替诺福韦凝胶试验中的试验参与披露及凝胶使用行为
AIDS Care. 2014;26(12):1521-5. doi: 10.1080/09540121.2014.938014.
9
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.女性口服和阴道暴露前预防用药的经历:南非约翰内斯堡的VOICE-C定性研究
PLoS One. 2014 Feb 21;9(2):e89118. doi: 10.1371/journal.pone.0089118. eCollection 2014.
10
Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?撒哈拉以南非洲地区 HIV 临床试验中的妊娠问题:是同意还是避孕失败?
PLoS One. 2013 Sep 10;8(9):e73556. doi: 10.1371/journal.pone.0073556. eCollection 2013.